Page last updated: 2024-08-22

clodronic acid and Invasiveness, Neoplasm

clodronic acid has been researched along with Invasiveness, Neoplasm in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (8.33)18.2507
2000's5 (41.67)29.6817
2010's5 (41.67)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Chen, Y; Ma, C; Shao, B; Zhang, F; Zhou, Y1
Aloisio, GM; Amelio, AL; Brekken, RA; Castrillon, DH; Cuevas, I; DeBerardinis, RJ; Lea, JS; Miller, DS; Nakada, Y; Peña, CG; Saatcioglu, HD; Wong, KK; Zhang, S1
Benner, A; Berthel, A; Brand, K; Buechler, MW; Falk, CS; Grabe, N; Halama, N; Herrmann, T; Jaeger, D; Kahlert, C; Klupp, F; Koch, M; Krauss, J; Kunz, C; Lasitschka, F; Lerchl, T; Luckner-Minden, C; Luecke, S; Schneider, M; Springfeld, C; Suarez-Carmona, M; Suetterlin, T; Ulrich, A; Weitz, J; Zitvogel, L; Zoernig, I1
Fotovati, A; Hiraoka, K; Hosoi, F; Iguchi, H; Kimura, YN; Kuwano, M; Nagata, K; Ono, M; Osada, H; Shoda, T; Watari, K; Zenmyo, M1
Bayanga, K; Bechmann, I; Binder, C; Chuang, HN; Dehghani, F; Hanisch, UK; Heermann, S; Hoffmann, A; Klemm, F; Lohaus, R; Pukrop, T; Regen, T; Schulz, M; Siam, L; Stadelmann, C; Trümper, L; Van Rossum, D1
Chen, X; Li, Q; Qin, L; Wang, B; Wang, J; Zhao, S1
Allavena, P; Mantovani, A1
Glass, R; Kettenmann, H; Markovic, DS; Rooijen, Nv; Synowitz, M1
Kane, AB; Miselis, NR; Van Rooijen, N; Wu, ZJ1
Adami, S1
Boissier, S; Clézardin, P; Colombel, M; Delaissé, JM; Delmas, P; Ebetino, FH; Ferreras, M; Magnetto, S; Peyruchaud, O1
Härkönen, PL; Lakkakorpi, PT; Väänänen, HK; Virtanen, SS1

Reviews

2 review(s) available for clodronic acid and Invasiveness, Neoplasm

ArticleYear
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment.
    Clinical and experimental immunology, 2012, Volume: 167, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzenesulfonates; Chemotaxis; Clodronic Acid; Cytokines; Dioxoles; Disease Progression; Humans; Immunity, Innate; Inflammation; Liposomes; Macrophages; Mice; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Prognosis; Pyridines; Sorafenib; Tetrahydroisoquinolines; Trabectedin; Tumor Escape; Tumor Microenvironment

2012
Bisphosphonates in prostate carcinoma.
    Cancer, 1997, Oct-15, Volume: 80, Issue:8 Suppl

    Topics: Alendronate; Biomarkers; Bone Diseases; Bone Neoplasms; Bone Resorption; Clinical Trials as Topic; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Male; Neoplasm Invasiveness; Osteoclasts; Pain; Prostatic Neoplasms

1997

Other Studies

10 other study(ies) available for clodronic acid and Invasiveness, Neoplasm

ArticleYear
Liposomal clodronate combined with Cisplatin or Sorafenib inhibits hepatocellular carcinoma cell proliferation, migration and invasion by suppressing FOXQ1 expression.
    Cellular and molecular biology (Noisy-le-Grand, France), 2020, Apr-20, Volume: 66, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Cisplatin; Clodronic Acid; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liposomes; Liver Neoplasms; Neoplasm Invasiveness; RNA, Messenger; Sorafenib

2020
LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment.
    The Journal of clinical investigation, 2015, Nov-02, Volume: 125, Issue:11

    Topics: Adenocarcinoma; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Chemokine CCL2; Clodronic Acid; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Macrophages; Mice; Neoplasm Invasiveness; Neoplasm Proteins; Protein Serine-Threonine Kinases; RNA Interference; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Specific Pathogen-Free Organisms; Transcription, Genetic; Tumor Microenvironment

2015
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients.
    Cancer cell, 2016, Apr-11, Volume: 29, Issue:4

    Topics: Adenocarcinoma; Apoptosis; Chemokine CCL5; Chemokines; Chemotaxis; Clinical Trials, Phase I as Topic; Clodronic Acid; Colorectal Neoplasms; Cyclohexanes; Humans; Interferon-alpha; Liver Neoplasms; Lung Neoplasms; Lymphocytes, Tumor-Infiltrating; Macrophages; Maraviroc; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Proteins; NG-Nitroarginine Methyl Ester; Phenylurea Compounds; Pilot Projects; Pyridines; Receptors, CCR5; STAT3 Transcription Factor; Survival Analysis; Triazoles; Tumor Cells, Cultured; Tumor Microenvironment

2016
Inhibition of bone and muscle metastases of lung cancer cells by a decrease in the number of monocytes/macrophages.
    Cancer science, 2008, Volume: 99, Issue:8

    Topics: Animals; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Disease Models, Animal; Female; Humans; Lung Neoplasms; Macrophages; Mice; Mice, Inbred BALB C; Monocytes; Muscle Neoplasms; Neoplasm Invasiveness; Pyrans; Spiro Compounds

2008
Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way.
    Glia, 2010, Volume: 58, Issue:12

    Topics: Bone Density Conservation Agents; Brain Neoplasms; Breast Neoplasms; Cell Movement; Cells, Cultured; Clodronic Acid; Coculture Techniques; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Indoles; Lipopolysaccharides; Male; Microarray Analysis; Microglia; Microscopy, Confocal; Neoplasm Invasiveness; Signal Transduction; Time Factors; Wnt Proteins

2010
Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice.
    BMC immunology, 2011, Aug-04, Volume: 12

    Topics: Adoptive Transfer; Animals; Cell Line, Tumor; Clodronic Acid; Cytokines; Disease Progression; Female; Histocompatibility Antigens Class II; Leukocyte Reduction Procedures; Liposomes; Lymphocyte Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasms; T-Lymphocytes; Tumor Microenvironment

2011
Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2.
    Journal of neuropathology and experimental neurology, 2005, Volume: 64, Issue:9

    Topics: Animals; Antimetabolites; Brain Neoplasms; Cell Line, Tumor; Clodronic Acid; Fluorescent Antibody Technique; Glioma; Humans; Liposomes; Male; Metalloproteases; Mice; Microglia; Microscopy, Confocal; Neoplasm Invasiveness; Organ Culture Techniques

2005
Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma.
    Molecular cancer therapeutics, 2008, Volume: 7, Issue:4

    Topics: Animals; Apoptosis; Bone Density Conservation Agents; Cell Proliferation; Clodronic Acid; Cytokines; Fluorescent Antibody Technique; Humans; In Situ Nick-End Labeling; Injections, Intraperitoneal; Liposomes; Macrophages; Mesothelioma; Mice; Mice, Inbred C57BL; Mice, Nude; Neoplasm Invasiveness; Peritoneal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2008
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases.
    Cancer research, 2000, Jun-01, Volume: 60, Issue:11

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Bone Neoplasms; Breast Neoplasms; Cell Adhesion; Cell Cycle; Cell Movement; Clodronic Acid; Collagen; Diphosphonates; Dose-Response Relationship, Drug; Drug Combinations; Flow Cytometry; Fluorometry; Humans; Ibandronic Acid; Imidazoles; Laminin; Male; Matrix Metalloproteinases; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Prostatic Neoplasms; Proteoglycans; Pyridines; Pyridinium Compounds; Tumor Cells, Cultured; Zinc; Zoledronic Acid

2000
Alendronate inhibits invasion of PC-3 prostate cancer cells by affecting the mevalonate pathway.
    Cancer research, 2002, May-01, Volume: 62, Issue:9

    Topics: Alendronate; Antimetabolites; Bone Neoplasms; Cell Movement; Clodronic Acid; Dose-Response Relationship, Drug; Humans; Male; Mevalonic Acid; Neoplasm Invasiveness; Prostatic Neoplasms; Tumor Cells, Cultured

2002